UK health advisers now recommend that all teenagers receive a free vaccine against meningitis B (MenB) at around the age of 15. The Joint Committee on Vaccination and Immunisation (JCVI) updated its guidance following an outbreak in Kent earlier this year, marking a shift from previous advice that said it was not necessary or cost effective.
JCVI Recommendation for Routine MenB Vaccination
The JCVI advisory group has formally requested that the government consider a routine MenB vaccination program for secondary school-aged people. According to Professor Wei Shen Lim, chair of the JCVI advisory group, the decision stems from “recent new evidence” regarding the transmission and severity of the disease. The committee reviewed input from meningitis charities and families affected by the illness, including those who experienced life-changing complications or the loss of loved ones.
Did you know?
Meningococcal disease spreads through close contact, such as kissing, sharing drinks, or sharing vapes. This is a primary reason the JCVI is targeting the 15-year-old age group.
Addressing the Risks of Meningitis B and Sepsis
Invasive meningococcal disease remains a rare but very serious illness. Infection with the MenB bacteria can lead to meningitis—inflammation of the lining of the brain—and sepsis, a life-threatening blood poisoning condition. Medical data indicates that these conditions can result in life-changing disabilities, including hearing loss, brain damage, and amputations.
Currently, the NHS offers the MenB vaccine to babies born on or after July 1, 2015, as babies are more likely to get invasive infections more often than other age groups. However, teenagers and young adults over age 11 have not received this jab. The new proposal aims to close this immunity gap by offering two doses at age 15, or a single “top-up” dose for those who were vaccinated as infants.
Financial and Policy Decisions Ahead
While the JCVI has provided the clinical recommendation, the final decision rests with ministers in each nation of the UK. The government must now determine whether the financial cost of providing this via the NHS is worth it. As a precaution, a one-off vaccination campaign is already being launched this summer, specifically targeting young people heading off to university for the first time.
Comparison: Current vs. Proposed Vaccination Strategy
| Group | Current Status | Proposed Status |
|---|---|---|
| Infants | Routine NHS offer | No change |
| 15-Year-Olds | Not routinely offered | Two-dose routine offer |
If you are a parent concerned about your child’s vaccination status, consult your GP or the NHS website for the latest updates on regional availability and private options.
Frequently Asked Questions (FAQ)
Why is the MenB vaccine being recommended for 15-year-olds now?
The JCVI updated its guidance following an outbreak in Kent and new evidence regarding the disease’s transmission among teenagers, who have not previously been covered by the routine infant vaccination program.
Is the vaccine currently free for teenagers?
A one-off summer campaign is currently targeting students heading to university. However, a permanent, routine offer for all 15-year-olds is still subject to government approval and funding decisions.
What are the symptoms of MenB?
MenB can cause meningitis and sepsis. It can lead to life-changing disabilities such as amputations, hearing loss and brain damage, and in some cases can be fatal.
Have questions about the changing vaccination landscape in the UK? Subscribe to our newsletter for the latest public health updates or join the conversation in the comments section below.
Worth a look